A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting

Table 4

Treatment related adverse events ( = 50).

	Dose of ramosetron
	0.3 mg, (%)		0.45 mg, (%)		0.6 mg, (%)
	Grade 1	Grade 2	Grade 1	Grade 2	Grade 1	Grade 2
AST	1 (6)	1 (6)	0	0	1 (6)	0
ALT	2 (12)	1 (6)	1 (7)	0	2 (11)	0
r-GTP	1 (6)	1 (6)	0	0	1 (6)	0
Constipation	3 (18)	1 (6)	0	0	3 (17)	0
Rash	0	0	1 (7)	0	0	0
ECG QT prolongation	0	0	0	0	1 (6)	0